Publications

December 2010
Supplement

Denmark: Globalization and the Welfare State (PPT)

By: Arthur A. Daemmrich

December 2010 (Revised April 2012)
Background Note

Stalemate at the WTO: TRIPS, Agricultural Subsidies, and the Doha Round

By: Arthur A. Daemmrich

This note analyzes disputes over intellectual property enforcement and agricultural trade barriers at the center of the Doha Round of World Trade Organization (WTO) negotiations. Fundamental principles of intellectual property rights and agricultural subsidies are... View Details

Keywords: Agribusiness; Trade; Globalization; Governance; International Relations; Intellectual Property; Agreements and Arrangements; Agriculture and Agribusiness Industry; Pharmaceutical Industry

January 2009 (Revised July 2009)
Case

Targanta Therapeutics: Hitting a Moving Target

By: Arthur A. Daemmrich

This case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful... View Details

Keywords: Decision Choices and Conditions; Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Business and Government Relations; Business Strategy; Biotechnology Industry; Pharmaceutical Industry

2004
Book

R&D Meets M&A: Proceedings of the 2003 Conference on Innovation and Creativity in Chemical R&D

By: Arthur A. Daemmrich

Keywords: Research and Development; Mergers and Acquisitions; Conferences; Innovation and Invention; Creativity; Science

Read Now

January 2000
Article

The Tragedy of the Commoners: Biotechnology and its Publics

By: Arthur A. Daemmrich

Keywords: Biotechnology Industry

December 2000
Article

Risk versus Risk: Tragic Choices in Drug Regulation in the United States and Germany

By: Arthur A. Daemmrich

Keywords: Risk and Uncertainty; Decision Choices and Conditions; Health; United States; Germany

fall 2002
Article

Science and Medicine in Court: Expert Testimony in the German Thalidomide Trial

By: Arthur A. Daemmrich

Keywords: Science; Health; Courts and Trials; Pharmaceutical Industry; Germany

Article

Invisible Monuments and the Costs of Pharmaceutical Regulation: Twenty-Five Years of Drug Lag Debate

By: Arthur A. Daemmrich

Keywords: Cost; Health; Governing Rules, Regulations, and Reforms; Communication

June 2016 (Revised February 2017)
Case

The Role of Real Estate in Endowment Portfolios: The Case of Christ Church, Oxford

By: David Chambers, Elroy Dimson, Arthur I Segel and Eva Steiner

The case centers on Christ Church's Treasurer, James Lawrie, who is contemplating his options for investing a portion of the College's endowment in real estate. Approximately 1/3 of the total $690 million endowment was allocated towards real estate, much higher than... View Details

Keywords: Real Estate; Endowment Management; Endowments; United Kingdom; Oxford; Portfolio Allocation; Higher Education; Investment Portfolio; Property; Corporate Finance; Financial Services Industry; United Kingdom

June 2011 (Revised October 2012)
Case

Patagonia Sur: For-Profit Land Conservation in Chile

By: Arthur I Segel, Nicolas Ibanez and Jay Verjee

Warren Adams founded Patagonia Sur in 2007 as one of the world's first for-profit land conservation businesses. His goal was to purchase over 100,000 acres of land in southern Chile and to run a variety of sustainable businesses to generate annual returns for... View Details

Keywords: Business Model; Environmental Sustainability; Profit; Investment; For-Profit Firms; Entrepreneurship; Investment Return; Revenue; Risk and Uncertainty; Capital; SWOT Analysis; Real Estate Industry; Chile

March 2011 (Revised June 2012)
Teaching Note

Brazil: Leading the BRICs? (TN)

By: Arthur A. Daemmrich and Aldo Musacchio

Teaching Note for 711024. View Details

Keywords: Brazil

13 Mar 2007
First Look

First Look: March 13, 2007

site for paper: http://www.bepress.com/cas/vol1/iss3/art3/ Identity Negotiation Processes Amidst Diversity: Understanding the Influence of Social Identity and Status Differences Authors:Jeffrey T. Polzer and Heather M. Caruso Publication:In Diversity at Work, edited... View Details

Keywords: Martha Lagace

19 Dec 2006
First Look

First Look: December 19, 2006

percent of the 366 pairs of cross elasticities are sign asymmetric. Finally, we find that the occurrence of negatively signed cross elasticities can be partially explained by a set of hypothesized relationships between cross-price... View Details

Keywords: Sean Silverthorne

13 Jan 2009
First Look

First Look: January 13, 2009

nonprofits and corporations can create value for society more effectively by applying strategy principles to philanthropy. Part V explores the link between strategy and leadership. Risk Frameworks and Biomonitoring: Distributed Regulation... View Details

Keywords: Martha Lagace

28 Apr 2009
First Look

First Look: April 28, 2009

show that the same behaviors produce more ethical condemnation when they happen to produce bad rather than good outcomes, even if the outcomes are determined by chance. Our studies show that individuals judge behaviors as less ethical,... View Details

Keywords: Martha Lagace

17 May 2011
First Look

First Look: May 17

valuations in first financing rounds. Further econometric tests suggest that, as predicted by the theory, this effect is driven by unobservable heterogeneity, and it is more pronounced in teams that make... View Details

Keywords: Sean Silverthorne

April 2011 (Revised October 2011)
Teaching Note

U.S. Healthcare Reform: International Perspectives (TN)

By: Arthur A. Daemmrich and Elia Cameron

Teaching Note for #710-040 and 711-103. View Details

Keywords: Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States